BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Wednesday reported a loss of $12 million in its second quarter.
The Boston-based company said it had a loss of 12 cents per share.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 12 cents per share.
In the final minutes of trading on Wednesday, the company's shares hit $2.51. A year ago, they were trading at $5.71.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZIOP at https://www.zacks.com/ap/ZIOP